Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform

Angela M. Starks, Enrique Aviles, Daniela M. Cirillo, Claudia M. Denkinger, David L. Dolinger, Claudia Emerson, Jim Gallarda, Debra Hanna, Peter S. Kim, Richard Liwski, Paolo Miotto, Marco Schito, Matteo Zignol

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Continued progress in addressing challenges associated with detection and management of tuberculosis requires new diagnostic tools. These tools must be able to provide rapid and accurate information for detecting resistance to guide selection of the treatment regimen for each patient. To achieve this goal, globally representative genotypic, phenotypic, and clinical data are needed in a standardized and curated data platform. A global partnership of academic institutions, public health agencies, and nongovernmental organizations has been established to develop a tuberculosis relational sequencing data platform (ReSeqTB) that seeks to increase understanding of the genetic basis of resistance by correlating molecular data with results from drug susceptibility testing and, optimally, associated patient outcomes. These data will inform development of new diagnostics, facilitate clinical decision making, and improve surveillance for drug resistance. ReSeqTB offers an opportunity for collaboration to achieve improved patient outcomes and to advance efforts to prevent and control this devastating disease.

Original languageEnglish
Pages (from-to)S141-S146
JournalClinical Infectious Diseases
Volume61
DOIs
Publication statusPublished - Oct 15 2015

Fingerprint

Tuberculosis
Drug Resistance
Public Health
Organizations
Pharmaceutical Preparations
Therapeutics
Clinical Decision-Making

Keywords

  • database
  • drug resistance
  • Mycobacterium tuberculosis

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Starks, A. M., Aviles, E., Cirillo, D. M., Denkinger, C. M., Dolinger, D. L., Emerson, C., ... Zignol, M. (2015). Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform. Clinical Infectious Diseases, 61, S141-S146. https://doi.org/10.1093/cid/civ610

Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform. / Starks, Angela M.; Aviles, Enrique; Cirillo, Daniela M.; Denkinger, Claudia M.; Dolinger, David L.; Emerson, Claudia; Gallarda, Jim; Hanna, Debra; Kim, Peter S.; Liwski, Richard; Miotto, Paolo; Schito, Marco; Zignol, Matteo.

In: Clinical Infectious Diseases, Vol. 61, 15.10.2015, p. S141-S146.

Research output: Contribution to journalArticle

Starks, AM, Aviles, E, Cirillo, DM, Denkinger, CM, Dolinger, DL, Emerson, C, Gallarda, J, Hanna, D, Kim, PS, Liwski, R, Miotto, P, Schito, M & Zignol, M 2015, 'Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform', Clinical Infectious Diseases, vol. 61, pp. S141-S146. https://doi.org/10.1093/cid/civ610
Starks, Angela M. ; Aviles, Enrique ; Cirillo, Daniela M. ; Denkinger, Claudia M. ; Dolinger, David L. ; Emerson, Claudia ; Gallarda, Jim ; Hanna, Debra ; Kim, Peter S. ; Liwski, Richard ; Miotto, Paolo ; Schito, Marco ; Zignol, Matteo. / Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform. In: Clinical Infectious Diseases. 2015 ; Vol. 61. pp. S141-S146.
@article{17690822ee26455aa54a6648fc464083,
title = "Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform",
abstract = "Continued progress in addressing challenges associated with detection and management of tuberculosis requires new diagnostic tools. These tools must be able to provide rapid and accurate information for detecting resistance to guide selection of the treatment regimen for each patient. To achieve this goal, globally representative genotypic, phenotypic, and clinical data are needed in a standardized and curated data platform. A global partnership of academic institutions, public health agencies, and nongovernmental organizations has been established to develop a tuberculosis relational sequencing data platform (ReSeqTB) that seeks to increase understanding of the genetic basis of resistance by correlating molecular data with results from drug susceptibility testing and, optimally, associated patient outcomes. These data will inform development of new diagnostics, facilitate clinical decision making, and improve surveillance for drug resistance. ReSeqTB offers an opportunity for collaboration to achieve improved patient outcomes and to advance efforts to prevent and control this devastating disease.",
keywords = "database, drug resistance, Mycobacterium tuberculosis",
author = "Starks, {Angela M.} and Enrique Aviles and Cirillo, {Daniela M.} and Denkinger, {Claudia M.} and Dolinger, {David L.} and Claudia Emerson and Jim Gallarda and Debra Hanna and Kim, {Peter S.} and Richard Liwski and Paolo Miotto and Marco Schito and Matteo Zignol",
year = "2015",
month = "10",
day = "15",
doi = "10.1093/cid/civ610",
language = "English",
volume = "61",
pages = "S141--S146",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform

AU - Starks, Angela M.

AU - Aviles, Enrique

AU - Cirillo, Daniela M.

AU - Denkinger, Claudia M.

AU - Dolinger, David L.

AU - Emerson, Claudia

AU - Gallarda, Jim

AU - Hanna, Debra

AU - Kim, Peter S.

AU - Liwski, Richard

AU - Miotto, Paolo

AU - Schito, Marco

AU - Zignol, Matteo

PY - 2015/10/15

Y1 - 2015/10/15

N2 - Continued progress in addressing challenges associated with detection and management of tuberculosis requires new diagnostic tools. These tools must be able to provide rapid and accurate information for detecting resistance to guide selection of the treatment regimen for each patient. To achieve this goal, globally representative genotypic, phenotypic, and clinical data are needed in a standardized and curated data platform. A global partnership of academic institutions, public health agencies, and nongovernmental organizations has been established to develop a tuberculosis relational sequencing data platform (ReSeqTB) that seeks to increase understanding of the genetic basis of resistance by correlating molecular data with results from drug susceptibility testing and, optimally, associated patient outcomes. These data will inform development of new diagnostics, facilitate clinical decision making, and improve surveillance for drug resistance. ReSeqTB offers an opportunity for collaboration to achieve improved patient outcomes and to advance efforts to prevent and control this devastating disease.

AB - Continued progress in addressing challenges associated with detection and management of tuberculosis requires new diagnostic tools. These tools must be able to provide rapid and accurate information for detecting resistance to guide selection of the treatment regimen for each patient. To achieve this goal, globally representative genotypic, phenotypic, and clinical data are needed in a standardized and curated data platform. A global partnership of academic institutions, public health agencies, and nongovernmental organizations has been established to develop a tuberculosis relational sequencing data platform (ReSeqTB) that seeks to increase understanding of the genetic basis of resistance by correlating molecular data with results from drug susceptibility testing and, optimally, associated patient outcomes. These data will inform development of new diagnostics, facilitate clinical decision making, and improve surveillance for drug resistance. ReSeqTB offers an opportunity for collaboration to achieve improved patient outcomes and to advance efforts to prevent and control this devastating disease.

KW - database

KW - drug resistance

KW - Mycobacterium tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84943411464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943411464&partnerID=8YFLogxK

U2 - 10.1093/cid/civ610

DO - 10.1093/cid/civ610

M3 - Article

AN - SCOPUS:84943411464

VL - 61

SP - S141-S146

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -